- Home
- Publications
- Publication Search
- Publication Details
Title
Health economic impact of liquid biopsies in cancer management
Authors
Keywords
-
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2018-07-28
DOI
10.1080/14737167.2018.1505505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating tumor cells count as a predictor of survival in lung cancer
- (2018) Konstantinos Syrigos et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
- (2018) Glenn Heller et al. JOURNAL OF CLINICAL ONCOLOGY
- What do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?
- (2017) Reyes Bernabé et al. EUROPEAN JOURNAL OF CANCER
- Circulating tumor cells: clinical validity and utility
- (2017) Luc Cabel et al. International Journal of Clinical Oncology
- Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility
- (2017) A. Berghuis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Going With the Flow: The Promise and Challenge of Liquid Biopsies
- (2017) M.J. Friedrich JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature
- (2017) Maarten J. IJzerman et al. PHARMACOECONOMICS
- Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer
- (2017) Koen Degeling et al. VALUE IN HEALTH
- Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
- (2016) W. J. Janni et al. CLINICAL CANCER RESEARCH
- Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
- (2016) David Lorente et al. EUROPEAN UROLOGY
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
- (2016) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiling and DNA methylation analyses of CTCs
- (2016) Evi S. Lianidou Molecular Oncology
- Imaging biomarker roadmap for cancer studies
- (2016) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide
- (2016) Mark C. Markowski et al. PROSTATE
- A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models
- (2016) Koen Degeling et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Clinical Application of Liquid Biopsies
- (2016) P. Mickey Williams et al. JAMA Oncology
- Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
- (2015) Amelie Schramm et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis
- (2015) Q. Lv et al. Clinical & Translational Oncology
- Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer
- (2015) Matthew G. Krebs et al. Clinical Colorectal Cancer
- Importance of circulating tumor cells in newly diagnosed colorectal cancer
- (2015) GUUS VAN DALUM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Clinical Utility of Circulating Tumor Cells in Metastatic Breast Cancer
- (2015) Francois-Clement Bidard et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care
- (2015) Daniel Schneider et al. Public Health Genomics
- Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
- (2014) Amir Goldkorn et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
- (2014) Jeffrey B. Smerage et al. JOURNAL OF CLINICAL ONCOLOGY
- Solidifying Liquid Biopsies: Can Circulating Tumor Cell Monitoring Guide Treatment Selection in Breast Cancer?
- (2014) Aditya Bardia et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
- (2014) Brigitte Rack et al. JNCI-Journal of the National Cancer Institute
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Interpretation of Changes in Circulating Tumor Cell Counts
- (2014) Frank A.W. Coumans et al. Translational Oncology
- Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics
- (2013) W. Onstenk et al. CANCER TREATMENT REVIEWS
- The economic value of personalized medicine tests: what we know and what we need to know
- (2013) Kathryn A Phillips et al. GENETICS IN MEDICINE
- Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context
- (2013) Patricia Danzon et al. HEALTH ECONOMICS
- Economic burden of cancer across the European Union: a population-based cost analysis
- (2013) Ramon Luengo-Fernandez et al. LANCET ONCOLOGY
- Current Methodological Issues in the Economic Assessment of Personalized Medicine
- (2013) Lieven Annemans et al. VALUE IN HEALTH
- Reflections on Market Access for Personalized Medicine: Recommendations for Europe
- (2013) Katherine Payne et al. VALUE IN HEALTH
- Economic Incentives for Evidence Generation: Promoting an Efficient Path to Personalized Medicine
- (2013) Adrian Towse et al. VALUE IN HEALTH
- Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
- (2012) François-Clément Bidard et al. CANCER AND METASTASIS REVIEWS
- Challenges in the Enumeration and Phenotyping of CTC
- (2012) F. A. W. Coumans et al. CLINICAL CANCER RESEARCH
- Paying for personalized care: Cancer biomarkers and comparative effectiveness
- (2012) Rahber Thariani et al. Molecular Oncology
- How Comparative Effectiveness Research Can Help Advance ‘Personalized Medicine’ In Cancer Treatment
- (2011) Scott D. Ramsey et al. HEALTH AFFAIRS
- Personalized medicine: Factors influencing reimbursement
- (2009) Lisa M. Meckley et al. HEALTH POLICY
- Understanding the Medical and Nonmedical Value of Diagnostic Testing
- (2009) David W. Lee et al. VALUE IN HEALTH
- Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer
- (2009) M. Craig Miller et al. Journal of Oncology
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- The Evidence Dilemma In Genomic Medicine
- (2008) Muin J. Khoury et al. HEALTH AFFAIRS
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started